Investing.com - Autobio Diagnostics reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Autobio Diagnostics announced earnings per share of ¥0.63 on revenue of ¥1.21. Analysts polled by Investing.com EPS of ¥0.66 on revenue of ¥1.37B.
Autobio Diagnostics 's are down 26% and is trading at ¥73.60 , still down 8.68% from its 52 week high of ¥80.60 set on Monday, October 24, 2022.
Autobio Diagnostics follows other major Healthcare sector earnings this month
Autobio Diagnostics's report follows an earnings missed by Aier Eye Hospital Group on Wednesday, who reported EPS of ¥0.15 on revenue of ¥4.94B, EPS of ¥0.1722 on revenue of ¥5.7B.
Imeik had missed expectations on Wednesday with third quarter EPS of ¥1.85 on revenue of ¥604.5M, for EPS of ¥1.95 on revenue of ¥692.11M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar